Dergiler / The Anatolian Journal of Cardiology / 2015 / Cilt: 15 - Sayı: 1

Prognostic value of mean platelet volume in patients undergoing elective percutaneous coronary intervention

Sayfa
25–30
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Moreover, it may be useful for risk stratification in such cases.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: We sought to determine the role of mean platelet volume (MPV) for predicting long-term outcomes of elective percutaneous coronary intervention (PCI).Methods: On the basis of retrospective cohort study, we collected characteristics of 680 patients undergoing elective PCI from October 2005 to August 2010.
📊
Temel Bulgular & Veri:The patients who had preoperative MPV were assessed for developing major adverse cardiac events (MACE) during 1-year follow-up.
💡
Sonuç & Katkı:Moreover, it may be useful for risk stratification in such cases.
🔬Tür:Araştırma Makalesi
📍Kapsam:2005 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: We sought to determine the role of mean platelet volume (MPV) for predicting long-term outcomes of elective percutaneous coronary intervention (PCI).Methods: On the basis of retrospective cohort study, we collected characteristics of 680 patients undergoing elective PCI from October 2005 to August 2010. The patients who had preoperative MPV were assessed for developing major adverse cardiac events (MACE) during 1-year follow-up. They were categorized into two groups including MPV <9.6 fL (n=89) and MPV >=9.6 fL (n=92). Data were analyzed using t-test, chi-square test, Pearson correlation, receiver operating characteristic (ROC) curve and logistic regression.Results: One-hundred eighty one patients (26.6%) met inclusion criteria. The MACE was observed in 29 patients (16%); and its rate in low- and high-MPV groups was 11.2% and 20.7%, respectively (p=0.084). MPV was significantly higher in the patients with left ventricular ejection fraction (LVEF) <40% compared with that of >=40% (p<0.001). There were a significant and negative correlation between MPV and platelet count (r=-0.305, p<0.001), and significant and positive correlations between MPV and platelet distribution width (PDW) and platelet large cell ratio (P-LCR) (r=0.615, p<0.001 and r=0.913, p<0.001; respectively). The best MPV cut-off point was 9.25 fL; the sensitivity and specificity were 79% and 38%, respectively. Elevated MPV was the best predictor of MACE at 1-year follow-up (OR=11.359, 95% CI 2.481-51.994, p=0.002).Conclusion: The results indicate that preoperative MPV is an independent predictor of the MACE at 1-year follow-up in the patients undergoing elective PCI. Moreover, it may be useful for risk stratification in such cases.

🔖

Bu Makaleye Atıf Yap

SEYYED-MOHAMMADZAD, M. H., ESKANDARI, R., REZAEI, Y., KHADEMVATANI, K., MEHRPOOYA, M., ROSTAMZADEH, A., ZAHEDİ, A. (2015). Prognostic value of mean platelet volume in patients undergoing elective percutaneous coronary intervention. The Anatolian Journal of Cardiology, Cilt: 15 - Sayı: 1, 25–30. https://ajindex.com/articles/365892

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Yang A, Pizzulli L, Luderitz B. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res 2006
  2. [CrossRef] 2. Bonello L, Paganelli F, Arpin-Bornet M, Auquier P, Sampol J, DignatGeorge F, et al. Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events. J Thromb Haemost 2007
  3. [CrossRef] 3. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007
  4. [CrossRef] 4. Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J 2001
  5. [CrossRef] 5. Muscari A, De Pascalis S, Cenni A, Ludovico C, Castaldini N, Antonelli S, et al. Determinants of mean platelet volume (MPV) in an elderly population: relevance of body fat, blood glucose and ischaemic electrocardiographic changes. Thromb Haemost 2008
  6. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010
  7. [CrossRef] 7. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004
  8. [CrossRef] 8. Kario K, Matsuo T, Nakao K. Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol 1992
  9. [CrossRef] 9. Ekiz O, Balta I, Şen BB, Rifaioğlu EN, Ergin C, Balta S, et al. Mean platelet volume in recurrent aphthous stomatitis and Behçet disease. Angiology 2014
  10. [CrossRef] 10. Demirkol S, Balta S, Küçük U, Çelik T. Mean platelet volume may indicate early diagnosed gastric cancer based on inflammation. Platelets 2013 Jun 17. [Epub ahead of print] [CrossRef] 11. Balta S, Demirkol S, Çelik T, Akgül EO. Mean platelet volume as a surrogate marker of long-term mortality in patients undergoing percutaneous coronary intervention. Am J Cardiol 2013
  11. [CrossRef] 12. Choi SW, Choi DH, Kim HW, Ku YH, Ha SI, Park G. Clinical outcome prediction from mean platelet volume in patients undergoing percutaneous coronary intervention in Korean cohort: Implications of more simple and useful test than platelet function testing. Platelets 2013 Aug 2. [Epub ahead o